enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA approves new type of schizophrenia drug - AOL

   www.aol.com/news/fda-approves-type-schizophrenia...

   The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...

3. FDA approves 1st new drug for schizophrenia in more ... - AOL

   www.aol.com/fda-approves-1st-drug-schizophrenia...

   Jake Goodman, MD, MBA is a psychiatry resident physician and a member of the ABC News Medical Unit. FDA approves 1st new drug for schizophrenia in more than 30 years originally appeared on abcnews ...

4. FDA Approves the First New Schizophrenia Drug in Decades - AOL

   www.aol.com/fda-approves-first-schizophrenia...

   N o new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ...

5. Ulotaront - Wikipedia

   en.wikipedia.org/wiki/Ulotaront

   The Brief Negative Symptom Scale (BNSS) has been used to assess the effect of Ulotaront on the negative symptoms of schizophrenia. [16] In July 2023, the pharmaceutical company behind the drug announced that the drug had failed to outperform placebo in the treatment of acutely psychotic patients with schizophrenia, as measured by the PANSS. [17]

6. Schizophrenia In America - The Huffington Post

   highline.huffingtonpost.com/articles/en/stop-the...

   It was through her work that, in the early 2000s, she heard about a radical new approach to schizophrenia that had been developed by researchers in Australia. Tamara was shocked to discover that this program took a very different attitude toward schizophrenia than nearly everyone who had treated her brother.

7. Bristol Myers' schizophrenia drug reduces symptoms without ...

   www.aol.com/news/bristol-myers-schizophrenia...

   "Current antipsychotic treatments are associated with a number of adverse effects, including adverse metabolic profiles, increases in weight . Bristol Myers' schizophrenia drug reduces symptoms ...

8. Brilaroxazine - Wikipedia

   en.wikipedia.org/wiki/Brilaroxazine

   RECOVER-2 is a confirmatory 4-week, randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of 450 acute schizophrenia patients, where patients will receive brilaroxazine 30 mg, 50 mg, or placebo once daily. Completion is expected in Q2 2025 and brilaroxazine FDA new drug application (NDA) submission is expected in Q3 ...

9. Roluperidone - Wikipedia

   en.wikipedia.org/wiki/Roluperidone

   Minerva believed that the findings of this second trial supported the claim that the drug was an effective agent for the treatment of negative symptoms in schizophrenia. However, in October 2022, FDA sent Minerva a refusal to file letter pertaining to the New Drug Application for roluperidone for treating negative symptoms in schizophrenia ...